Key result
Ischemic post-conditioning with the glycogen synthase kinase 3 beta inhibitor lithium chloride attenuated myocardial ischemia/reperfusion injury-induced brain injury in diabetic rats.
Why the study?
Does ischemic post-conditioning with lithium chloride reduce brain injury induced by myocardial ischemia/reperfusion in diabetic rats?
Does ischemic post-conditioning with lithium chloride reduce brain injury induced by myocardial ischemia/reperfusion in diabetic rats?
In a diabetic rat model, ischemic post-conditioning with a GSK-3β inhibitor attenuated brain injury induced by myocardial ischemia/reperfusion.
Answers are grounded in this paper and cite their sources.
Does not alter clinical practice in diabetic ischemia; leaves open translation of GSK-3β inhibition to human cardioprotection.
Myocardial ischemia/reperfusion injury can lead to severe brain injury. Glycogen synthase kinase 3 beta is known to be involved in myo-cardial ischemia/reperfusion injury and diabetes mellitus. However, the precise role of glycogen synthase kinase 3 beta in myocardial ischemia/reperfusion injury-induced brain injury is unclear. In this study, we observed the effects of glycogen synthase kinase 3 beta on brain injury induced by myocardial ischemia/reperfusion injury in diabetic rats. Rat models of diabetes mellitus were generated via intraperitoneal injection of streptozotocin. Models of myocardial ischemia/reperfusion injury were generated by occluding the anterior descending branch of the left coronary artery. Post-conditioning comprised three cycles of ischemia/reperfusion. Immunohistochemical staining and western blot assays demonstrated that after 48 hours of reperfusion, the structure of the brain was seriously damaged in the experimental rats compared with normal controls. Expression of Bax, interleukin-6, interleukin-8, terminal deoxynucleotidyl transferase dUTP nick end labeling, and cleaved caspase-3 in the brain was significantly increased, while expression of Bcl-2, interleukin-10, and phospho-glycogen synthase kinase 3 beta was decreased. Diabetes mellitus can aggravate inflammatory reactions and apoptosis. Ischemic post-conditioning with glycogen synthase kinase 3 beta inhibitor lithium chloride can effectively reverse these changes. Our results showed that myocardial ischemic post-conditioning attenuated myocardial ischemia/reperfusion injury-induced brain injury by activating glyco-gen synthase kinase 3 beta. According to these results, glycogen synthase kinase 3 beta appears to be an important factor in brain injury induced by myocardial ischemia/reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2017) studied Myocardial ischemia/reperfusion injury-induced brain injury in diabetes mellitus. Ischemic post-conditioning with glycogen synthase kinase 3 beta inhibitor lithium chloride vs. Normal controls and experimental rats without post-conditioning was evaluated on Brain injury markers (expression of Bax, IL-6, IL-8, TUNEL, cleaved caspase-3, Bcl-2, IL-10, and phospho-GSK-3 beta). Ischemic post-conditioning with the glycogen synthase kinase 3 beta inhibitor lithium chloride attenuated myocardial ischemia/reperfusion injury-induced brain injury in diabetic rats.
Synapse has enriched 10 related papers. Consider them for comparative context: